zgc:77058 is a zebrafish gene identified in genomic studies, with expression patterns and functional correlations documented in developmental and neurological research. While the term "zgc:77058 Antibody" is not explicitly defined in the literature, antibodies targeting this gene product are inferred to be tools for detecting its protein in experimental models, particularly in zebrafish studies .
zgc:77058 exhibits stage-specific expression during zebrafish development and shows correlations with genes involved in neuronal and metabolic processes.
| Positive Correlation (r) | Gene | Negative Correlation (r) | Gene |
|---|---|---|---|
| 0.235 | gng3 | -0.099 | aldob |
| 0.224 | sncb | -0.099 | ccng1 |
| 0.223 | stmn1b | -0.090 | vamp3 |
| 0.221 | rtn1b | -0.088 | eif4ebp3l |
| (Source: Daniocell, 2025) |
Key findings:
Strongest positive correlations with gng3 (guanine nucleotide-binding protein) and sncb (synuclein beta), both linked to neuronal signaling .
Negative correlations with aldob (aldolase B, a glycolytic enzyme) and ccng1 (cell cycle regulator) .
Data from zebrafish studies highlight dynamic expression across embryonic stages:
| Stage Range | Anatomical Region |
|---|---|
| 20–25 somites | Prim-5 (early brain) |
| Prim-15 to Prim-25 | Developing neural tube |
| High-pec to Long-pec | Peripheral nervous system |
| (Source: ZFIN, 2004) |
Notably, zgc:77058 is enriched in neural tissues during mid-to-late embryogenesis, suggesting a role in neurodevelopment .
While direct studies on zgc:77058 antibodies are absent, zebrafish models using this gene provide insights into neurodegenerative diseases:
Parkinson’s Disease (PD): zgc:77058 was differentially expressed in zebrafish mutants for gch1, a PD risk gene involved in tetrahydrobiopterin synthesis .
Microglial Activity: In gch1-deficient zebrafish, zgc:77058 showed altered expression alongside genes regulating microglial phagocytosis (e.g., irg1l) .
Antibodies targeting zgc:77058 would require:
Epitope Specificity: Custom development using recombinant protein fragments or synthetic peptides .
Validation: Functional assays (e.g., Western blot, immunohistochemistry) to confirm binding in zebrafish tissues .
Cross-Reactivity Screening: Ensure no off-target binding to paralogs like rtn1a or stmn2a .
Functional Annotation: The exact role of zgc:77058 remains uncharacterized, necessitating knockout models paired with antibody-based protein localization .
Therapeutic Potential: If linked to conserved pathways (e.g., neurotransmitter synthesis), zgc:77058 antibodies could aid in studying human neurological disorders .
zgc:77058 is a gene expressed in zebrafish (Danio rerio) that has drawn research interest due to its expression patterns and potential functional significance. The gene shows positive correlation with several neuronal markers including gap43, stmn1b, and elavl4, suggesting possible roles in neuronal development or function . Researchers typically use zgc:77058 antibodies to investigate protein expression patterns across developmental stages and in various tissue contexts. The protein's detection through immunological methods helps establish its spatial and temporal distribution, which can provide insights into its biological function in zebrafish development and physiology.
The commercially available zgc:77058 antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . These techniques allow researchers to detect and quantify zgc:77058 protein in various sample types. For ELISA applications, the antibody enables protein quantification in solution, while Western blotting permits size-based detection of the protein in tissue or cell lysates. The antibody has been specifically tested with Danio rerio samples, making it appropriate for zebrafish research models but potentially limiting its use in cross-species studies without additional validation.
Sample preparation is critical for successful zgc:77058 antibody applications. For Western blotting, tissues should be homogenized in appropriate lysis buffers containing protease inhibitors to prevent protein degradation. The antibody is stored in a buffer containing 50% glycerol and 0.01M PBS at pH 7.4 with 0.03% Proclin 300 as a preservative . To maintain proper antibody performance, samples should be prepared in compatible buffers, typically PBS-based solutions that maintain protein structure and epitope accessibility. When working with zebrafish tissues, particular attention should be paid to fixation methods that preserve epitope integrity while enabling sufficient tissue penetration for immunohistochemical applications.
Proper experimental controls are crucial when working with the zgc:77058 antibody. Negative controls should include samples where the primary antibody is omitted or replaced with non-specific IgG from the same species (rabbit) . Positive controls should ideally include tissues or cells known to express zgc:77058, based on correlated gene expression data . For definitive validation, knockdown or knockout models of zgc:77058 can provide powerful negative controls. Additionally, peptide competition assays, where the antibody is pre-incubated with excess recombinant zgc:77058 protein (the immunogen), can confirm binding specificity by demonstrating signal reduction in the presence of the competing antigen.
Analysis of gene expression correlation provides valuable insight into potential functional relationships of zgc:77058. The gene shows significant positive correlation with multiple neuronal markers and cytoskeletal components as detailed in the following table:
| Positively Correlated Genes | Correlation Value (r) | Potential Functional Association |
|---|---|---|
| gng3 | 0.235 | Neuronal G-protein signaling |
| sncb | 0.224 | Synapse function |
| stmn1b | 0.223 | Microtubule dynamics |
| rtn1b | 0.221 | Endoplasmic reticulum shaping |
| elavl4 | 0.220 | Neuronal RNA processing |
| stmn2a | 0.215 | Neuronal growth and regeneration |
| tuba1c | 0.211 | Cytoskeletal structure |
| stx1b | 0.210 | Synaptic vesicle function |
| gap43 | 0.203 | Axonal growth |
Conversely, zgc:77058 shows negative correlation with genes involved in cell proliferation (mki67, r = -0.076), ribosome biogenesis (rsl1d1, r = -0.074), and metabolism (aldob, r = -0.099) . These correlation patterns suggest potential involvement in neuronal differentiation processes, potentially as part of post-mitotic neuronal maturation pathways. When designing experiments with zgc:77058 antibody, researchers should consider examining these correlated genes for potential functional relationships or shared regulatory mechanisms.
While the antibody is validated for ELISA and Western blot applications , immunohistochemistry (IHC) applications may present additional challenges. The polyclonal nature of the commercially available antibody can introduce batch-to-batch variability in epitope recognition. Furthermore, the confirmation that the antibody was generated against recombinant Danio rerio zgc:77058 protein suggests that the three-dimensional conformation of epitopes may be critical for recognition. Fixation methods that alter protein conformation could potentially impact antibody binding efficiency in IHC applications.
Advanced researchers should consider optimizing fixation protocols specifically for zgc:77058 detection, potentially testing both cross-linking fixatives (paraformaldehyde) and precipitating fixatives (methanol/acetone) to determine which best preserves epitope accessibility. Additionally, epitope retrieval methods may need to be systematically tested, including heat-induced and enzymatic approaches, to optimize signal-to-noise ratio in tissue sections.
The correlation data between zgc:77058 and other genes can be leveraged for sophisticated experimental designs. Researchers could develop co-localization studies using antibodies against highly correlated proteins like gng3 (r = 0.235) or stmn1b (r = 0.223) to investigate potential functional complexes or shared subcellular localization. Additionally, the negative correlations with cell cycle regulators like mki67 (r = -0.076) suggest potential experiments examining zgc:77058 expression during cell cycle progression or differentiation.
Advanced experimental approaches might include temporal analysis of zgc:77058 expression relative to its correlated gene partners during key developmental transitions or in response to specific signaling pathway perturbations. This integrated approach combines protein-level detection via the antibody with contextual understanding derived from gene expression networks to generate more comprehensive biological insights.
The zgc:77058 antibody should be stored at -20°C or -80°C upon receipt, and repeated freeze-thaw cycles should be avoided to maintain antibody integrity . The storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 helps stabilize the antibody . For working solutions, aliquoting the stock antibody prevents repeated freeze-thaw cycles that can lead to protein denaturation and loss of activity. When maintaining antibody stocks long-term, temperature monitoring systems are recommended to prevent inadvertent thawing events that could compromise antibody performance.
Non-specific binding can be mitigated through several methodological approaches. Optimization of blocking conditions is critical, with options including different blocking agents (BSA, milk, commercial blockers) at various concentrations (typically 3-5%). The antibody, being affinity-purified and polyclonal in nature , may benefit from extended blocking times (1-2 hours at room temperature or overnight at 4°C) to minimize background. Additionally, increasing the number or duration of wash steps can significantly reduce non-specific signal. For particularly challenging samples, pre-adsorption of the antibody with non-relevant zebrafish proteins might selectively remove antibodies with off-target affinity while preserving specific binding to zgc:77058.
Discrepancies between protein detection via antibody methods and mRNA expression levels are common in molecular biology research. When facing such inconsistencies with zgc:77058, researchers should first verify the specificity of the antibody through appropriate controls. Subsequently, methodological approaches to investigate discrepancies might include:
Analyzing protein stability through cycloheximide chase experiments to determine if post-translational regulation affects protein abundance
Investigating post-transcriptional regulation through RNA-protein binding assays to identify factors that might suppress translation
Examining subcellular localization, as protein compartmentalization can affect extraction efficiency and apparent abundance
Quantifying absolute versus relative levels, as differences in detection sensitivity between protein and RNA methods can create apparent discrepancies
The RNA-binding protein ELAV family members (elavl3, r = 0.204; elavl4, r = 0.220) show positive correlation with zgc:77058, suggesting potential post-transcriptional regulation that might explain disparities between RNA and protein measurements.
While specific developmental expression data is not directly provided in the search results, the strong correlation with neuronal markers suggests potential enrichment during neurogenesis and neuronal differentiation stages. Researchers investigating developmental expression should design time-course experiments using the zgc:77058 antibody across key developmental milestones, particularly focusing on stages associated with neuronal specification, differentiation, and maturation (approximately 10-72 hours post-fertilization).
The correlation with cytoskeletal proteins like stmn1b (r = 0.223) and tuba1c (r = 0.211) further suggests potential roles in morphological development of neuronal structures. Immunohistochemical analysis using the zgc:77058 antibody during axon extension and synaptogenesis stages would be particularly informative for understanding its developmental functions.
When working specifically with neuronal tissues, where zgc:77058 appears to be enriched based on correlation data , permeabilization steps may need enhancement. Detergents like Triton X-100 (0.1-0.3%) or saponin (0.01-0.05%) can improve antibody access to intracellular epitopes while minimizing tissue disruption. Additionally, antigen retrieval methods, particularly sodium citrate buffer (pH 6.0) heat-mediated retrieval, may significantly enhance detection sensitivity in fixed brain tissues.
While the zgc:77058 antibody is specifically generated against and tested with Danio rerio samples , comparative approaches can extend research insights to other model systems. Sequence homology analysis of zgc:77058 across species can identify conserved domains that might be recognized by the antibody in closely related teleost species. Additionally, the correlation patterns with highly conserved neuronal proteins suggest functional pathways that might be investigated in other models even if direct antibody cross-reactivity is absent.
For translational approaches, researchers should identify potential mammalian orthologs of zgc:77058 through bioinformatic analysis. Although direct antibody application may not be possible across distant species, the biological pathways elucidated in zebrafish studies can inform experimental design in mammalian systems. Of particular translational relevance is the correlation with synaptic proteins like sncb (r = 0.224), stx1b (r = 0.210), and snap25a (r = 0.192) , suggesting potential roles in conserved synaptic mechanisms that could be investigated across model systems.
Analysis of zgc:77058 knockout phenotypes should be guided by the gene's correlation network . Given the strong positive correlations with neuronal markers, primary phenotypic analysis should focus on neuronal development, morphology, and function. Recommended analytical approaches include:
Quantitative morphometric analysis of neuronal structures, particularly examining parameters correlated with cytoskeletal components like stmn1b (r = 0.223) and tuba1c (r = 0.211)
Functional assays of synaptic transmission, motivated by correlations with synaptic proteins like snap25a (r = 0.192)
Transcriptomic analysis comparing wild-type and knockout models to assess perturbations in the correlated gene network
Behavioral assays to determine if neuronal circuit function is compromised in specific domains
For comprehensive phenotypic analysis, researchers should implement both acute (morpholino) and stable (CRISPR/Cas9) knockdown/knockout approaches, as these may reveal different aspects of zgc:77058 function due to potential compensatory mechanisms in stable genetic models.